Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03769467 |
Title | Tabelecleucel in Combination With Pembrolizumab in Subjects With EBV+ Nasopharyngeal Carcinoma (ATA129-NPC-202) |
Recruitment | Terminated |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Atara Biotherapeutics |
Indications | |
Therapies | |
Age Groups: | child | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | Duarte | California | 91010 | United States | Details | |
Stanford Hospital and Clinics | Palo Alto | California | 94305 | United States | Details | |
Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
Atlantic Health System / Morristown Medical Center | Morristown | New Jersey | 07962 | United States | Details | |
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health | New York | New York | 10016 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
University of Pennsylvania (Adults and Pediatrics) | Philadelphia | Pennsylvania | 19104 | United States | Details |